Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Telemonitoring for high-risk pregnant women in Pakistan

Official title: Feasibility of Implementing a Mobile Phone-based Telemonitoring Program to Support Pregnant Women at High-risk for Preeclampsia in Karachi, Pakistan

Run by University Health Network, Toronto · NCT05662696 · Data updated 2026-11-12

A mobile phone app called Raabta will let pregnant women at high risk for preeclampsia in Karachi, Pakistan, regularly track blood pressure and share data with clinicians to see if this helps catch problems earlier.

More Preeclampsia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment50 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedAugust 4, 2024
Main results expectedMarch 1, 2027
Study endsMarch 31, 2027
Registry record updatedJune 1, 2026
Trial IDNCT05662696 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women in the first or second trimester who are high-risk for preeclampsia and can read/understand Urdu, and who have a caregiver willing to participate in interviews.

Probably not a fit

Principle investigators will determine feasibility; some participants may not experience a clear clinical benefit during the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will test a mobile telemonitoring program for pregnant women at high risk of preeclampsia in Karachi. The Raabta app enables daily blood pressure measurements and data transmission to healthcare providers between antenatal visits. A mixed-methods approach will enroll about 50 participants to assess feasibility, including how well the technology works, potential barriers, and user experiences. The study builds on prior LMIC telemonitoring work but focuses on early risk detection outside routine community health worker visits. Data will be hosted by the Centre for Digital Therapeutics at UHN in Toronto, with local clinical sites overseeing implementation.

Why it matters

Potential benefit: If successful, Raabta could improve early detection and timely management of preeclampsia in high-risk pregnancies.

How similar studies have gone: Previous LMIC telemonitoring efforts showed promise but often relied on in-person visits by community health workers; this study tests a direct patient-facing app in a hospital-based LMIC setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women at high-risk for preeclampsia (HRPE) who are either in their first or second trimester of pregnancy. The definition of HRPE will follow that of the NICE guidelines that define pregnant women at HRPE as those who have one high-risk factor or more than one moderate risk factor for preeclampsia.
* Participants who can speak and read (at least at a rudimentary level with help from a caregiver) the Urdu language for ease of communication with the research team and to be able to use the telemonitoring system.
* Partners (almost always male husbands in the Pakistani culture) and/or other caregivers (e.g., mother and mother-in-law) of pregnant women \[for post-study interviews\]
* Clinicians and nurses involved in the implementation of the telemonitoring program \[for post-study interviews\]

Exclusion Criteria:

* Pregnant women at high-risk for preeclampsia who are admitted to hospital for the management of their preeclampsia condition

Where it's running

  • Jinnah Postgraduate Medical Centre
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.